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PREFACE 
The following document was completed as per requirement at Worcester Polytechnic Institute, 
submitted no later than April 30th, 2015.  
The following manuscript satisfies the WPI Major Qualifying Project requirement for 
Biology/Biotechnology and is titled “Sustained Reduction in Nosocomial Bloodstream 
Infections in the ICU Setting.” This project was advised by WPI faculty member Dr. Jill Rulfs 
and sponsored by the University of Massachusetts (UMASS) Medical School. This study was 
approved by the UMASS Medical School Institutional Review Board. 
The following study was conducted over the course of eleven months spanning from June 2014 
– April 2015; the study itself is a retrospective, data-based study examining bloodstream 
infections that occurred between October 1st 2004 and September 30th 2014 on the UMASS 
Medical Center campus. It was performed under the guidance of Dr. Richard T. Ellison III, 
Hospital Epidemiologist at UMASS Medical Center in Worcester, MA. Dr. Ellison has 
provided guidance, input, and many rounds of revision to this manuscript.  
Other members of this study are as follows. Dr. Stephen O. Heard is a hospital anesthesiologist 
and intensivist who was instrumental in the execution of the study regarding primary infections 
that prompted the need for this study. Dr. Heard contributed knowledge of hospital history to 
this manuscript and helped fund portions of the work. Dr. J. Matthias Walz is a hospital 
anesthesiologist and intensivist and is the primary author on a previous study regarding primary 
infections. Dr. Walz contributed knowledge on hospital history to this manuscript. Deborah A. 
Mack is the lead Infection Control Preventionist in the UMass Medical Center’s Infection 
Control Department. Debbie assisted with ascertaining missing data and patient information 
during the process of database curation. Dr. Eric Ruggieri is a statistician from Department of 
Mathematics and Computer Science at College of the Holy Cross in Worcester, MA. Dr. 
Ruggieri completed nearly all statistical analysis found within this manuscript and contributed 
to specific written portions of this paper. Dr. Michael Mitchell is the Microbiology Lab 
Manager at UMASS Medical School and provided information on the number of blood cultures 
performed at the hospital for analysis. Dr. Craig Lilly oversees the implementation of the 
electronic ICU monitoring system in use at the UMASS Medical Center, and assisted in the 
collection of patient acuity and outcome data for auxiliary analysis in this study. Karen E. 
Landry managed the database for the Critical Care Operations Committee (CCOC) from which 
the data for auxiliary analysis was obtained.  
This study was inspired by a study published in 2013 which included Walz, Ellison, Heard, 
Mack, and Landry and examined the effects of a multidisciplinary intervention approach on 
trends in central line-associated bloodstream infections (CLABSIs). After witnessing large 
decreases in the number of CLABSIs, there was interest in determining if multimodal 
intervention strategies had impacted secondary bloodstream infections in a similar manner. 
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From June 2011 through August 2011, I was tasked with compiling a database of the patients 
which met the criteria outlined by Dr. Ellison for this study. First, the study examined only 
patients from FY05 through FY14, a decade-long study period. Next, patients were to be 
included if they were placed in an ICU unit and contracted a bloodstream infection during their 
stay that could directly be attributed to hospital stay (nosocomial). This process involved 
narrowing down over 7,000 potential patient entries to approximately 850 entries. This process 
proved to be painstaking and lengthy, as the information had previously been maintained in 
Excel spreadsheets which were not formatted in the same manner, and often had missing pieces 
of patient information that were required. The summer was spent combing through these entries 
and finding missing data to produce one, complete, final database which included information 
on date, ICU location, BSI source, and causative organism for all qualifying ICU admissions. 
Upon completion of this database, the de-identified information was send to Dr. Ruggieri for 
analysis. After the analysis was completed, an abstract for the project was completed, and a 
presentation was made of the preliminary findings to the CCOC. 
In August, the abstract for this study was submitted for consideration to the Society of Critical 
Care Medicine for publishing in the journal Critical Care Medicine. (Note that the abstract in 
this report is longer than the abstract submitted with the e-CDR form, as this is the format in 
which it was submitted for publishing. In the interest of consistency, I chose to retain the full 
abstract for this report.) 
We received word on September 22nd that the abstract was accepted for the 2015 Critical Care 
Conference in Phoenix, AZ. The abstract (#486) was published in a special supplement to 
Critical Care Medicine, and I was invited to attend the conference in Phoenix in January 2015 
to do a poster presentation of the study. A poster was created and presented in the Infectious 
Disease category alongside top hospitals and institutions. A guided, moderated group of 
conference participants visited the poster and were able to ask questions and generate 
discussion regarding the study.  
Following the acceptance of the abstract, the project progressed to the next phase of creating a 
complete manuscript in order to ultimately submit the manuscript for publishing in this same 
journal. During this time, more analysis was conducted – referred to as “auxiliary analysis” – 
to look deeper into some potentially confounding variables that may have affected the study, 
as well as to attempt to determine the causes of the trends seen in the initial results. It was at 
this point that the help of Dr. Mitchell, Dr. Lilly, and Karen Landry was enlisted to obtain the 
appropriate data sets. One data set consisted of in-depth patient information (ie. ICU length of 
stay, glucose levels, APACHE IV scores) (about 32,000 entries) while the other documented 
the blood cultures drawn during the entire study period (about 135,000 entries). I worked very 
closely with Dr. Ruggieri in order to outline what analyses were needed based on the 
information in these data sets. The process of outlining the analyses, executing the analyses, 
and interpreting the analyses took through the end of C-term; writing of this manuscript took 
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place over the course of latter three terms of the year. This project was presented on Project 
Presentation Day in the Campus Center Odeum on Thursday, April 23rd, 2015.  
The manuscript below will likely continue to be modified as is necessary in order to submit it 
for publishing. However, for the purposes of this project, this paper can be considered 
complete. This paper’s main and true goal is to provide information to the members of the 
CCOC so they may assess the efficacy of the interventions in place and proceed with this new 
knowledge in planning future interventions. 
I am truly thankful for the opportunity to have worked with the Infection Control staff and 
other members of UMASS Medical Center/School on this project. Their knowledge, patience, 
encouragement, and support have made this project entirely possible. Enough cannot truly be 
said especially regarding the wonderful Infection Control Preventionists who exercised much 
patience with me on this project, constantly answering questions and clarifying information for 
me. Their kindness and willingness to assist removed much stress from the databasing portion 
of this project. Additionally, it has been a privilege to work alongside Dr. Ruggieri, who was 
always willing and able to answer questions and perform analysis, even while teaching classes 
at College of the Holy Cross. Finally, my sincerest thanks go to Dr. Richard Ellison, who 
initially provided me with the opportunity to work in Infection Control, then with motivation 
and guidance along the way to see this project through to its eventual submission for 
publication.  
Primary authorship on a study such as this was something that I never would have expected to 
achieve during my time as an undergraduate. The knowledge and experience gained through 
this project will be invaluable to me as I continue on to pursue my Master of Public Health 
degree, and for that, I am eternally grateful. 
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ABSTRACT  
BACKGROUND: Central line–associated bloodstream infections (CLABSIs) have decreased 
significantly throughout the last decade within intensive care units (ICUs). A concurrent 
reduction in the total number of bloodstream infections (BSIs) in ICUs should also be expected. 
We report trends in nosocomial ICU-associated BSIs in a tertiary care academic medical center 
for a 10-year time period. 
METHODS: This was a retrospective study of positive blood cultures from patients admitted 
to seven adult ICUs for the period FY2005 through FY2014. BSIs were evaluated and 
categorized according to Centers for Disease Control and Prevention (CDC) National 
Healthcare Safety Network (NHSN) definitions for primary BSIs and those secondary to 
another site. The rate of change for primary and secondary nosocomial BSIs was determined, 
as was the distribution of different organisms responsible for these BSIs.  
RESULTS: Across all ICUs, the rate of primary BSIs progressively fell from 2.11/1000 patient 
days in FY05 to 0.32/1000 patient days in FY14; an 85.0% decrease (P<0.0001). Secondary 
BSIs also progressively decreased from 3.56/1000 patient days to 0.66/1000 patient days; an 
81.4% decrease (P<0.0001). The total BSI rate per 1000 patient days decreased from 5.67 in 
FY05 to 0.98 FY14; an 82.8% decrease. The decrease in BSI rates remained significant after 
controlling for the number of blood cultures obtained and patient acuity. Both S. aureus and S. 
not-aureus infections exhibited notable changes, decreasing by 97.3% and 89.7% respectively; 
other species decreased 60-80% or remained constant.  
CONCLUSION: An increased focus on reducing nosocomial infections at the academic 
medical center during the last 10 years, including multimodal multidisciplinary efforts to 
prevent CLABSIs, pneumonia, Clostridium difficile disease, surgical site infections, and 
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urinary tract infections as well as to reduce the number of blood transfusions, has led to a 
progressive and sustained decrease in both primary and secondary nosocomial BSIs.  
KEYWORDS: bacteremia; nosocomial; blood stream infection 
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INTRODUCTION 
Nosocomial bloodstream infections (BSIs) are a prominent category of hospital-
acquired infections (HAIs), which are acquired after admission to the hospital for an 
unrelated reason. In 2008, bloodstream infections (BSIs) were ranked as the 11th major 
cause of death in the US (Goto & Al-Hasan, 2013). Based on a population-based study 
by Goto and Al-Hasan (2013), 100,000 of the estimated 536,000 – 628,000 BSI episodes 
in the US annually are nosocomial with a 15-30% fatality rate. In this same study, based 
on a surveillance-based system, as many as 250,000 nosocomial BSIs occur annually 
with this same fatality rate (Goto & Al-Hasan, 2013). Nosocomial BSIs increase 
morbidity and mortality, as well as hospital costs – between $23,000 - $56,000 per 
episode – and can extend length of stay for as much as 32 days (Kaye, et al., 2011). 
Therefore, it is in the best interest to hospital staff to implement measures to greatly 
reduce the number of nosocomial BSIs occurring in their facilities. 
 
The UMass Memorial Medical Center (UMMMC) is a 781-bed hospital located on two 
different campuses with seven adult ICUs.  Beginning in 2004, the hospital implemented 
a major, coordinated, multidisciplinary quality improvement initiative to reduce the 
number of central-line associated bloodstream infections (CLABSIs) in these units 
which successfully led to a significant decrease in these infections (Walz, et al., 2013). 
We tested the hypothesis that this decrease in CLABSIs was also associated with a 
decrease in the total number of hospital-acquired BSIs in these ICUs, including those 
infections secondary to another site. To test this hypothesis we undertook a retrospective 
analysis of all hospital-acquired BSIs that occurred in patients receiving care in the adult 
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UMMMC ICUs between 10/01/2004 and 09/30/2014. The study was approved by the 
University of Massachusetts Medical School Institutional Review Board.   
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METHODS 
The UMMMC adult ICUs include two medical units, two surgical units, one combined 
medical/surgical unit (composed of two smaller units), a neurological critical care and 
trauma unit, and a cardiac surgery and coronary care unit. Community-acquired (CA) 
and healthcare-acquired (HCA) BSIs were excluded from the analysis.  
  
All positive blood cultures were reviewed and categorized by UMMMC infection 
control practitioners in accordance with Centers for Disease Control and Prevention 
(CDC) National Healthcare Safety Network (NHSN) definitions for primary BSIs and 
those secondary to another site at the time of classification. This data had been 
maintained in spreadsheets until November 2010 (Microsoft Excel, Redmond, WA) and 
a dedicated infection control database thereafter (Theradoc, Premier, Charlotte, NC).  
 
Infections were initially classified into two broad categories: primary infections and 
secondary infections. Primary infections included infections designated as CLABSIs or 
as non-specific types of primary infections. Secondary infections included all other 
infections, which were then broken down into six main categories: gastrointestinal (GI), 
respiratory (Resp), surgical site (SSI), skin and soft tissue (SST), urinary tract (UTI), 
and ultiple/other/unknown (Mult/Other/Unk). This last category included infections 
attributed to multiple sources, where the source listed did not fall into one of the five 
main categories, or if the site of the infection was unknown. Infections were then 
stratified by the organism indicated as causative to the infection, as well as by ICU.  
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The majority of the organisms identified were categorized into one of the following 
groups: Staphylococcus aureus, Staphylococcus not-aureus, Enteric Gram-Negative 
Bacteria, Pseudomonas species, Candida species, and Enterococcus species. The 
category “Staph not-aureus” included all Staphylococcus species that were not S. 
aureus.  The category “Candida” contained all Candida species; “Pseudomonas” and 
“Enterococcus” were classified in the same manner. The category “Enteric Gram-
Negative Bacteria” includes: Citrobacter, Enterobacter, Escherichia, Klebsiella, 
Proteus, and Serratia species. Additionally, many organisms were only responsible for 
a few infections throughout the time period. In order to avoid skewing of the data, these 
organisms were grouped into a category defined as “Other.” This category contained the 
following organisms: Acinetobacter, Bacteroides, Clostridium, Corynebacterium, 
Lecleria, Leuconostoc, Peptostreptococcus, Stenotrophomonas, Stomatococcus, alpha-
hemolytic Streptococcus, Hafnia, Providencia, Cedecea, Cryptococcus, Haemophilus 
influenza, Peptoniphilus, and Morganella species. 
 
Additional information was obtained for further analysis. A custom report was used to extract 
relevant blood culture data from the Laboratory Information System (MEDITECH, Westwood, 
MA).  Data was imported into Microsoft Excel (Redmond, WA) for analysis.  Blood culture 
data was stored in a secure, restricted laboratory database. Auxiliary information regarding 
patient ICU stays was taken from the UMass Memorial ICU data repository using abstraction, 
privacy protection, data aggregation, and mapping techniques previously described (Lilly, 
Cody, & Zhao, 2011). Observations were entered by clinicians or transferred using a validated 
extract-transform-load process (Lilly, Landry, & Sood, 2014) from a clinical information 
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system and mapped to equivalent concepts in the ICU database. This database contained 
consistent physiological, laboratory, diagnosis, treatment, physical examination elements, 
microbiology, and nursing flow sheet data in the electronic record for every patient for the 
duration of their ICU stay; however, not all of this information was accessed for this study.  
Acuity was measured using the Acute Physiology and Chronic Health Evaluation (APACHE 
IV) software sublicensed from Cerner, Inc., (Kansas City, MO).   
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Statistical Analysis 
Differences in infection rates over time by fiscal year (10/01 – 9/30) were evaluated 
with a Poisson test (Lehmann & Romano, 2005).  Evaluation of the trend in infection 
rates was modeled by a Poisson regression model with a log link function (Dobson, 
1990) (McCullagh & Nelder, 1990) using the R (R Core Team, 2014) package glm2 
(Marschner, 2014). Fiscal year was modeled as a continuous fixed effect.  A logistic 
regression model with fiscal year as the independent variable was used to compare the 
rate of decrease of primary BSIs relative to secondary BSIs. Additionally, linear mixed 
effects analysis was performed using the R (R Core Team, 2014) package lme4 (Bates, 
Maechler, Bolker, & Walker, 2014) using restricted estimation by maximum likelihood. 
The number of blood stream infections per year was modeled using general linear mixed 
models (Graybill, 1976) with fiscal year as a continuous fixed effect and ICU as a 
random effect.  Indicator variables were added one at a time as fixed effects in order to 
evaluate the effect of interventions that were made in any given year.  A likelihood ratio 
test was used to evaluate the improvement in the model by inclusion of the indicator 
variables.  The final model contained only those terms found to be statistically 
significant.  P-values were obtained by likelihood ratio tests of the full model with the 
effect in question against the model without the effect in question.   
 
Trends in potential confounding variables such as the number of blood cultures obtained 
in the ICU, APACHE IV scores, and glucose levels were analyzed using linear 
regression models. Infection rates were adjusted for these variables where noted. 
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RESULTS 
Overall, there was an 82.8% decrease in total BSIs (P<0.001). Primary BSIs exhibited 
a significant 85.0% reduction when comparing FY05 to FY14, with a progressive 0.245 
fold reduction in the rate each year (P ≈ 10-16) (Table 1). In addition, there was a 
significant 81.4% reduction in secondary BSIs over the 10 year period with an annual 
rate fold reduction of 0.152 per year (P≈ 10-11) (Table 1). It was concluded that both 
primary and secondary infections decreased in a similar manner, although primary 
infections decreased at an approximately 11% faster rate (Figure 1, Supplementary 
Table 1). 
 
For secondary BSIs (Table 2), SSI-associated BSIs exhibited a 0.226-fold reduction (P 
<0.001), slightly larger than the 0.203-fold reduction (P ≈10-15) seen in respiratory 
infections. There was also a statistically significant decrease observed in GI-, UTI-, and 
SST-associated BSIs (P <0.001). The category encompassing all primary infections 
showed a 0.245-fold reduction (P ≈10-30). Overall, there was a decrease across all 
categories of primary and secondary infections (Table 2). A P-value was not calculated 
for the Mult/Unk/Other category, as it would not be meaningful to look for a trend in a 
group which does not have consistent characteristics.    
 
In an analysis by pathogen (Figure 2, Table 3), Staphylococcus not-aureus exhibited the 
largest decrease with a 0.300-fold decrease per year in the annual BSI rate, 84.5% of 
which were primary BSIs. Staphylococcus aureus exhibited a 0.191-fold decrease per 
year with reductions in BSIs where 21.5% were primary BSIs. All other pathogen 
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classes, including the “Other” category, exhibited at least a 0.100-fold decrease per year; 
all P-values were significant. Over the study period, overall fold reductions were greater 
than 50%, with Staphylococcus species exhibiting a decrease >80% (Supplementary 
Table 2 - 4). 
 
For each of these same categories, an overall percent reduction was calculated 
comparing the FY05 BSI rate to the FY14 rate (Supplementary Figure 4). In line with 
the annual fold reduction (Figure 2), Staphylococcus aureus exhibited a large overall 
reduction of 97.3%, while Staphylococcus non-aureus had a similar reduction of 89.7% 
overall. Candida species, Enterococcus species, Enteric Gram-Negative Bacteria¸ and 
Pseudomonas species had reductions of 67.1%, 68.0%, 78.7%, and 81.7%, respectively. 
The “Other” category decreased by 54.3%.  
 
In an analysis by unit (Figure 3, Table 4), there was a statistically significant decrease 
in BSI rates in all units with the exception of the cardiac surgery and coronary care unit, 
which exhibited low baseline rates. 
 
In order to address any potentially confounding trends, a regression model was used to 
analyze both the number of blood cultures obtained in the ICUs during the 10 year 
period as well as data on length of stay in the ICU, APACHE IV scores, glucose levels, 
vital status, and number of ICU stays.  There was a significant decline in the number of 
blood cultures obtained over the 10 year period (Figure 4), however, the decrease in BSI 
rates remains highly significant after controlling for this reduction. The average 
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APACHE IV scores also decreased minimally (68  66) between FY07 and FY14, but 
again the decrease in BSI rates remains significant after controlling for this change 
(Supplementary Figure 1). The decreasing BSI rates were associated with a drop in 
mortality rates, although the association is not statistically significant. Median glucose 
levels dropped significantly from 123.7 to 122.0 across the study period but do not 
represent a clinically relevant difference.  Finally, the total number of ICU stays per 
patient remained constant over time.  
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DISCUSSION 
The initial purpose of this study was to confirm that infections had not remained stagnant 
or increased, and to determine by how much nosocomial BSI rates had decreased, if at 
all (Asgeirsson, Gudlaugsson, Kristinsson, Heiddal, & Kristjansson, 2011). The major 
finding of our study is that we observed a significant decrease in not only primary but 
also secondary BSIs during the study period. The rates of primary and secondary 
infections decreased over time; primary infections fell at a slightly faster rate. 
 
The 85.0% decrease in primary infections was tightly temporally associated with the 
incorporation of a catheter bundle as well as education initiatives within the hospital 
system. The main features of these interventions have been previously reported by Walz 
et al. (2013). 
 
The 81.4% decrease in secondary infections was associated with directed preventative 
measures to reduce secondary infections and the predispositions that cause them. In 
September of 2004, the Critical Care Operations Committee (CCOC) was formed (in 
part) at UMass Medical Center to generate a set of clinical practice guidelines (CPGs) 
which would help provide standardized medical care to ICU patients. In the three years 
following its creation, the CCOC generated nearly one dozen CPGs covering many 
aspects of care: central line-related BSIs, ventilator-associated pneumonia (VAP), 
sedation holidays, glycemic control, weaning from mechanical ventilation, transfusion 
criteria, sepsis, catheter-associated urinary tract infections (CAUTIs), and more. These 
CPGs, combined with general education initiatives regarding best practice, almost 
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certainly contributed to this large decline seen in secondary infections. Additionally, the 
creation and implementation of the e-ICU system described by Lilly, Cody, and Zhao 
(2011) resulted in an increased availability of intensivists in the hospital, which may 
have contributed as well. 
 
It is possible to deduce potential associations between specific results and specific 
interventions. One example of this is the 0.203-fold decrease seen in respiratory 
infections. It is likely that this drop was associated with the implementation of specific 
CPGs (VAP, sedation holidays, weaning) as well as increased monitoring for head-of-
bed elevation. Another example pertains to the large drop in Staphylococcus not-aureus 
(SNA) infections. Between 2005 and 2006, specific CPGs, in addition to the catheter 
bundle described by Walz et al.  (2013), were deliberately targeted at reducing primary 
infections related to central line catheters. Staphylococcus not-aureus (SNA) is a 
common skin commensal that is often causative of primary BSIs due to inadequate 
maintenance of the line. Between FY06 and FY07, a large drop SNA was seen, and it is 
known that 84.5% of all SNA infections were primary infections. Therefore, the data 
suggests that the drop in SNA was associated with the implementation of direct 
intervention pertaining to central lines. These are just two examples of potential 
associations seen within this study. 
 
During the study period, two changes were made to NHSN definitions that impacted our 
study, one regarding the definition of contaminants and the other regarding ICU length 
of stay requirements for nosocomial infections.  
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In January of 2008, the NHSN definition was altered to include contaminants as a 
category for blood culture results. Initially, blood cultures were classified as either true 
positives or false positives. In order for an infection to be considered a “laboratory 
confirmed” bloodstream infection (LCBI), there was to be no infection at another site in 
addition to one of the following criteria: at least one culture positive for a recognized 
pathogen; the same organism found in at least two positive blood cultures isolated from 
two separate sites; or an organism found in at least one positive blood culture and the 
doctor applies antimicrobial therapy. Beginning in January 2008, this third criteria was 
removed. In the NHSN manual, the definition for LCBIs subsequently changed to 
remove “common skin contaminant is cultured from at least one blood culture from a 
patient with an intravascular line, and the physician institutes appropriate antimicrobial 
therapy.” This altered classifications to now account for a class of contaminants in which 
one culture was positive for a common skin commensal. This class includes many types 
of organisms seen in this study, including Corynebacterium, Bacillus, Streptococcus, 
and, most noteably, Staphylococcus non-aureus species. 
 
A second definition change occurred in January of 2013. Previously, the NHSN manual 
stated that, in order for an infection to be attributable to a specific location, patients were 
required to remain in that location for at least 48 hours. As per this rule, prior to January 
2013, exclusions were based on this 48-hour rule. Beginning in January 2013, the 
definition was changed so that patients were required to remain in the ICU for at least 
two midnights if they were admitted directly to the ICU from the Emergency 
Department; alternatively, if the patient was admitted to the hospital then transferred to 
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the ICU later, the 48-hour rule still applied and the patient must have been in the ICU 
for at least 48 hours in order to have the infection attributed to that ICU stay. 
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STRENGTHS AND LIMITATIONS 
The main strength of this study is that it encompasses seven different ICU locations 
which handled different types of patients including trauma, neurological, and cardiac 
populations over the course of a decade. Overall, P-values for the analysis performed 
were often extremely low, demonstrating very low probability of false attribution. 
Additionally, the auxiliary data analysis done examined over 32,000 separate ICU 
admissions, making the data very thorough. A large amount of care was put into assuring 
that all data involved in this study was complete, organized, and accurate. 
 
There are limitations to the data used in this study. First and foremost, this study is a 
retrospective study, and therefore relied solely on the accuracy and completeness of 
previously maintained data. The main limitation is that multiple interventions were 
implemented during the study period, resulting in a multimodal intervention. 
Accordingly, it is not possible to identify which component parts of the intervention 
were most responsible for the outcome.  
 
During the study period, two aforementioned major definition changes occurred which 
impacted this study. These definition changes had the potential to bias the study results 
in two ways: contributing to an artifactual reduction in BSIs, and reducing the acuity of 
the patients in the study. To address these potentially confounding factors, auxiliary 
analysis was performed that accommodated these changes. We were able to determine 
that these changes very likely did not affect the outcomes of our study.  
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The definition change regarding contaminants could have potentially contributed to the 
large drop in Staphylococcus non-aureus infections. However, the definition change 
occurred in January 2008 (in FY08), and the major drop occurred between October 2006 
and March 2007, which are considered FY07. Therefore, it is unlikely that the definition 
change was causative of this large decrease. The definition change may have had a 
minor role in the small drop in BSI rates per 1000 patients seen between FY08 and 
FY09. However, there continued to be a steady, sustained decrease throughout the 
following six years after the definition change, which allowed us to deduce no major 
link between the results and the definition change. 
 
The definition change regarding ICU length of stay in order to qualify an infection as 
nosocomial had the potential to confound the auxiliary analysis performed during this 
study.  
 
After the definition change, the two midnights rule applying to direct admissions was 
also applied to this circumstance regarding those who were transferred to an ICU from 
the hospital ward, where the 48-rule should have been applied. This was due to an 
inability to exclude transfer patients based on the information available; however this 
ultimately included more patients as opposed to excluding too many patients. Since 
transfer patients were included who only remained in the ICU for two midnights and not 
48 hours, there is potential that a small group of patients who were likely healthier 
(spending less time in the hospital) were included, which could have decreased the 
average APACHE IV score for this time period. Additionally, this general NHSN 
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change led to more – and also likely somewhat healthier – patients being included in the 
study post-January 2013 as they were required to remain in the hospital less time, and 
hospital length of stay often correlates with acuity of illness. Because of these new 
inclusions, it became important to determine if APACHE scores decreased over that 
time thereby requiring a re-analysis of the data using the correct 48 hour rule. However, 
APACHE scores for January 2013-September 2014 actually increased slightly, 
confirming that the inclusion of these patients did not skew the APACHE IV scores.  
 
In summary, our study found that the rate of secondary nosocomial BSIs in the adult 
ICUs steadily decreased throughout the study period alongside primary nosocomial 
BSIs. Across all classification categories, causative organisms, and ICU locations (with 
the exception of one ICU location), rates of both secondary and primary nosocomial 
BSIs declined by over 80%. Our study demonstrates that the interventions, both 
technical and educational, direct and indirect, put into place during the study period 
were effective in greatly reducing hospital-acquired BSIs in the ICU setting.  
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FIGURES & TABLES 
 
 
Figure 1: Overall rates of primary and secondary BSIs for 10 year study period. 
 
Table 1: Total BSI rate fold reduction and percent reduction stratified by 
primary/secondary classification. Note the fold reduction and respective P-value followed 
by percent reduction and respective P-value. 
 
Infection 
Subclass 
Fold 
Reduction 
95% CI 95% Lower 
Bound 
P-Value       
(FOLD RED) 
% 
Reduction 
P-Value 
(% RED) 
Primary .245 .201 - .287 .210 ~10-30 85.0 ~10-11 
Secondary .152 .121 - .182 .127 ~10-26 81.4 ~10-16 
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Table 2: Total BSI rate reduction stratified by source subclass. Note confidence intervals, 
lower bounds, and P-values for trends in each class. 
 
Infection Subclass Fold Reduction 95% CI 95% Lower Bound P-Value for Trend 
Primary .245 .201 - .287 .210 ~10-30 
GI .131 .066 - .192 .079 .00001 
Respiratory .203 .150 - .254 .160 ~10-15 
SSI .226 .112 - .326 .135 .00002 
SST .141 .030 - .239 .052 .0040 
UTI .124 .046 - .195 .062 .0003 
Mult/Unk/Other    NS 
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Figure 2: Total BSI rate stratified by causative organism class. 
 
 
Table 3: Total BSI fold reduction stratified by causative organism class. Note confidence 
intervals, lower bounds, and P-values for trends in each class. 
 
Organism Fold Reduction 95% CI 95% Lower Bound P-Value for Trend 
Candida .100 .032 - .163 .045 .0009 
Enterococcus .182 .117 - .243 .130 ~10-9 
Enteric Gram-
Negative Bacteria 
.137 .081 - .189 .092 ~10-7 
Pseudomonas .202 .084 - .304 .108 .0002 
Staph Aureus .191 .131 - .247 .143 ~10-11 
Staph not-Aureus .300 .240 - .354 .252 ~10-23 
Other .165 .074 - .247 .093 .0001 
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Figure 3: Total BSI rate stratified by associated ICU location. 
 
 
Table 4: Total BSI fold reduction stratified by ICU location. Note confidence intervals, 
lower bounds, and P-values for trends in each location. 
 
Organism Fold Reduction 95% CI 95% Lower Bound P-Value for Trend 
2 ICU .195 .143 - .243 .154 ~10-15 
Lakeside 3 -0.026 -.237 to + .148 -.190 .7340 
Lakeside 2 .128 .063 - .188 .076 .00001 
3 ICU .208 .146 - .265 .159 ~10-12 
6 ICU .153 .097 - .206 .108 ~10-9 
7 ICU .202 .142 - .258 .154 ~10-12 
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Figure 4: Comparison of annual number of blood cultures drawn and fiscal year. 
Annual total is based on how many cultures were drawn (as opposed to how many bottles 
were cultured). 
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SUPPLEMENTARY FIGURES & TABLES 
 
Supplementary Table 1: Comparison of primary and secondary nosocomial BSI rates 
over time. Rate is given in number of BSIs per 1000 patient days. Bottom row displays total 
percentage of annual nosocomial BSIs categorized as primary infections. 
 
Type 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Primary 2.108 2.477 1.577 1.201 0.964 0.520 0.361 0.132 0.345 0.315 
Secondary 3.564 2.916 2.329 2.702 2.294 2.014 1.248 0.695 1.225 0.662 
% Primary 37.2 45.9 40.4 30.8 29.6 20.5 22.4 16.0 22.0 31.5 
 
Supplementary Table 2: Distribution of causative organisms by fiscal year. 
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Supplementary Table 3: Total number of BSIs stratified by causative organism. Top 
half of table displays exact number of infections. Bottom half of table displays annual BSI 
rate per 1000 patient days for each organism class. 
 
ORGANISM 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Totals:           
Candida (Yeast) 15 11 13 23 21 11 12 1 14 6 
Enterococcus 18 17 28 20 18 6 5 3 7 7 
Enteric Gram-
Negative Bacteria 
27 22 22 27 19 22 11 10 13 7 
Pseudomonas 9 7 4 6 6 3 2 1 2 2 
Staph Aureus 30 22 18 17 18 16 11 7 9 1 
Staph Not Aureus 40 43 17 19 11 9 7 1 3 5 
Other 9 13 10 9 5 12 2 2 2 5 
 
Rates:           
Candida (Yeast) 0.575 0.439 0.488 0.767 0.698 0.357 0.394 0.033 0.440 0.189 
Enterococcus 0.690 0.679 1.052 0.667 0.598 0.195 0.164 0.099 0.220 0.221 
Enteric Gram-
Negative Bacteria 
1.035 0.879 0.826 0.901 0.632 0.715 0.361 0.331 0.408 0.221 
Pseudomonas 0.345 0.280 0.150 0.200 0.199 0.097 0.066 0.033 0.063 0.063 
Staph Aureus 1.150 0.879 0.676 0.567 0.598 0.520 0.361 0.232 0.283 0.032 
Staph Not Aureus 1.533 1.718 0.638 0.634 0.366 0.292 0.230 0.033 0.094 0.158 
Other 0.345 0.519 0.376 0.300 0.166 0.390 0.066 0.066 0.063 0.158 
 
Supplementary Table 4: Percent reduction in total nosocomial BSIs stratified by 
causative organism. Percent reduction directly compares FY05 and FY14. 
 
Organism Subclass % Reduction P-Value 
Candida 67.1 .0039 
Enterococcus 68.0 .0017 
Enteric Gram-Negative Bacteria 78.7 ~10-5 
Pseudomonas 81.7 .0023 
Staph Aureus 97.3 ~10-11 
Staph not-Aureus 89.7 ~10-10 
Other 54.3 .0435 
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Supplementary Figure 1: Average APACHE IV scores by month. 
 
 
